Emergence of the ST307 clone carrying a novel insertion element MITEKpn1 in the mgrB gene among carbapenem-resistant Klebsiella pneumoniae from Moscow, Russia.
Carbapenem-resistant (Carba-R) Klebsiella pneumoniae represents a major nosocomial pathogen with only few antimicrobials, including colistin, remaining active against it, but the emergence of colistin-resistant (Col-R) bacteria is compromising colistin activity. Here, we examined a collection of 159 Carba-R K. pneumoniae recovered at three hospitals in Moscow. These isolates demonstrated resistance to cephalosporins (100%), ciprofloxacin (93%), fosfomycin (90%), netilmicin (82%), gentamicin (84%), and amikacin (50%). The rate of colistin resistance (a minimal inhibitory concentration (MIC) >2 mg/L, by the broth microdilution method) was 45%; 7% of isolates were tigecycline-resistant. Among 18 discovered sequence types (STs), isolates of five lineages including ST307 (n=46, 29%), ST395 (n=40, 25%), ST377 (n=17, 10%), ST48 (n=17, 11%), and ST23 (n=16, 10%) dominated the bacterial population. In 146 (92%) Carba-R K. pneumoniae, the carriage of a blaOXA-48-like carbapenemase gene was detected; 11 (7%) and 2 (1.3%) isolates harbored blaNDM-1 and blaKPC-3, respectively. Among 71 Col-R isolates, colistin MICs ranged from 4 to >1024 mg/L with MIC50=2 mg/L and MIC90=512 mg/L. All Col-R isolates were tested mcr-1-negative. In 19 (27%) Col-R isolates, inactivation of mgrB by insertion sequence (IS) 1A, IS1R, ISKpn14, ISKpn26, and a novel miniature inverted repeat transposable element (MITE) Kpn1 was revealed. The carriage of MITEKpn1 was restricted to six ST307 isolates and affected mgrB at nucleotide position 75. mgrB deletion was observed in four (6%) Col-R isolates; in addition, in three (4%) mgrB-wild-type-carrying isolates, PmrA and/or PmrB were altered. Thus, blaOXA-48-like-carrying Col-R ST307 K. pneumoniae is emerging as a dominant clone in Moscow.